EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of the Prioritization of Diagnostics in National Action Plans for Antimicrobial Resistance

Georgia Lamb iD, Scott J C Pallett, Esmita Charani iD, Emmanuel Marx Kanu iD, Saleh A Alqahtani, Maria Virginia Villegas, Luke S P Moore

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciag020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Georgia Lamb und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infection, Barts Health NHS Trust, Royal London Hospital, London, United Kingdom. Hauptthemen laut MEDLINE: Drug Resistance, Bacterial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinically diagnosing antimicrobial resistance (AMR) remains a challenge, with significant variation in countries’ readiness and ability to address it. This study explores how diagnostic capabilities feature in national action plans (NAPs) for AMR, to respond to and manage infections in human health.

Methods

A targeted analysis was conducted of available NAPs of World Health Organization member states. NAPs were analyzed using predefined search terms and an analytical framework for diagnostic modality, key diagnostic activities (laboratory capacity, external quality assessment, surveillance, antimicrobial stewardship, and research) and key performance indicators (KPIs) specific to diagnostics.

Results

Of the 142 NAPs analyzed, 136/142 (95.8%) included diagnostics, mostly in the context of surveillance (131/142 [92.3%]) and building laboratory capacity (113/142 [79.6%]). Culture-based diagnostics appeared in 124/142 (87.3%) NAPs, point-of-care (POC) diagnostics in 47/142 (33.1%), and laboratory-based molecular diagnostics in 47/142 (33.1%). POC diagnostics were included most frequently in high-income country (HIC) NAPs (24/44 [54.5%]), and NAPs of the European region (21/37 [56.8%]). Diagnostic-specific KPIs were found in 35/142 (24.6%) NAPs, and KPIs specific to POC diagnostics in 9/142 (6.3%). Diagnostic KPIs were included most frequently in NAPs of the African Region (15/36 [41.7%]) and low- and middle-income countries (13/42 [31.0%]).

Conclusions

While diagnostics feature in most NAPs, POC diagnostics are underrepresented, particularly in low- and middle-income countries lacking diagnostic infrastructure and resources. The lack of KPIs, particularly in HICs, prevents effective evaluation. This study highlights the need for improved strategic planning to ensure NAP objectives are translated into real-world deliverable action to manage AMR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, BacterialHumansWorld Health OrganizationAntimicrobial StewardshipAnti-Bacterial AgentsRapid Diagnostic TestsPoint-of-Care Systems

Stichwörter der Autor:innen

POCantimicrobial stewardshipdiagnosticspoint-of-care

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infection, Barts Health NHS Trust, Royal London Hospital, London, United Kingdom.
  • Clinical Infection Department, Chelsea and Westminster Hospital, London, United Kingdom.
  • Centre of Defence Pathology, Royal Centre for Defence Medicine, Queen Elizabeth Hospital, Birmingham, United Kingdom.
  • Division of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
  • Masanga Medical Research Unit, Masanga Hospital, Masanga, Sierra Leone.
  • Centre for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: Georgia Lamb, Esmita Charani, Emmanuel Marx Kanu

Förderung

  • Wellcome Trust

Zitieren

APA

Lamb, G., Pallett, S. J. C., Charani, E., Kanu, E. M., Alqahtani, S. A., Villegas, M. V., & Moore, L. S. P. (2026). Assessment of the Prioritization of Diagnostics in National Action Plans for Antimicrobial Resistance. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag020

Vancouver

Lamb G, Pallett SJC, Charani E, Kanu EM, Alqahtani SA, Villegas MV, et al. Assessment of the Prioritization of Diagnostics in National Action Plans for Antimicrobial Resistance. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag020

BibTeX
@article{Lamb2026,
  author = {Lamb, Georgia and Pallett, Scott J C and Charani, Esmita and Kanu, Emmanuel Marx and Alqahtani, Saleh A and Villegas, Maria Virginia and Moore, Luke S P},
  title = {Assessment of the Prioritization of Diagnostics in National Action Plans for Antimicrobial Resistance},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag020}
}
Kostenlos starten →